Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study

Gut

Volumn 67, Issue 1, 2018, Pages 120-127

  Fan, Xiaozhou ^a   Alekseyenko, Alexander V ^b   Wu, Jing ^a   Peters, Brandilyn A ^a   Jacobs, Eric J ^c   Gapstur, Susan M ^c   Purdue, Mark P ^d   Abnet, Christian C ^d   Stolzenberg Solomon, Rachael ^d   Miller, George ^a,e   Ravel, Jacques ^f   Hayes, Richard B ^a,e   Ahn, Jiyoung ^a,e  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

PANCREAS

Indexed keywords

RNA 16S;

ADULT; AGED; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIUM CARRIER; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUSOBACTERIA; HUMAN; LEPTOTRICHIA; MAJOR CLINICAL STUDY; MALE; MOUTH FLORA; PANCREAS ADENOCARCINOMA; POPULATION BASED CASE CONTROL STUDY; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RNA SEQUENCE; TANNERELLA FORSYTHIA; ADENOCARCINOMA; HETEROZYGOTE; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOUTH; PANCREAS TUMOR; PERIODONTIUM; PROCEDURES;

ADENOCARCINOMA; AGED; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; CARRIER STATE; CASE-CONTROL STUDIES; FEMALE; FUSOBACTERIA; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; MOUTH; PANCREATIC NEOPLASMS; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84992055617     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-312580     Document Type: Article

References (54)

1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. Bethesda, MD, based on November 2 SEER data submission, posted to the SEER web site, 3 April 2016. http://seer. cancer. gov/csr/ 1975-2010/
2. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013;144:1252-61.
3. Iodice S, Gandini S, Maisonneuve P, et al. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008;393:535-45.
4. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008;134:95-101.
5. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003;89:519-23.
6. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol 2010;192:5002-17.
7. Slocum C, Kramer C, Genco CA. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis. J Intern Med 2016;280:114-28.
8. Homann N, Tillonen J, Meurman JH, et al. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 2000;21:663-8.
9. Moye ZD, Zeng L, Burne RA. Fueling the caries process: carbohydrate metabolism and gene regulation by Streptococcus mutans. J Oral Microbiol 2014;6:24878-92.
10. Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 2012;33:1055-8.
11. Michaud DS, Joshipura K, Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US Male health professionals. J Natl Cancer Inst 2007;99:171-5.
12. Hiraki A, Matsuo K, Suzuki T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomarkers Prev 2008;17:1222-7.
13. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ, et al. Tooth loss, pancreatic cancer, and Helicobacter pylori. Am J Clin Nutr 2003;78:176-81.
14. Hujoel PP, Drangsholt M, Spiekerman C, et al. An exploration of the periodontitiscancer association. Ann Epidemiol 2003;13:312-16.
15. Michaud DS, Izard J, Wilhelm-Benartzi CS, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 2013;62:1764-70.
16. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010;8:481-90.
17. Calle EE, Rodriguez C, Jacobs EJ, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002;94:2490-501.
18. Feigelson HS, Rodriguez C, Welch R, et al. Successful genome-wide scan in paired blood and buccal samples. Cancer Epidemiol Biomarkers Prev 2007;16:1023-5.
19. Hayes RB, Reding D, Kopp W, et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21:349S-55S.
20. Wu J, Lin I, Hayes RB, et al. Comparison of DNA extraction methods for human oral microbiome research. Br J Med Med Res 2014;4:1980-91.
21. Wu J, Peters BA, Dominianni C, et al. Cigarette smoking and the oral microbiome in a large study of American adults. ISME J 2016;10:2435-46.
22. Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control 2012;23:399-404.
23. Nossa CW, Oberdorf WE, Yang LY, et al. Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroentero 2010;16:4135-44.
24. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
25. Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 2011;21:494-504.
26. Chen T, Yu WH, Izard J, et al. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford) 2010;2010:baq013.
27. Lozupone C, Knight R. UniFrac: a New Phylogenetic Method for Comparing Microbial Communities. Appl Environ Microbiol 2005;71:8228-35.
28. Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci 2003;14:927-30.
29. Newman MG. Carranza's clinical periodontology. Philadelphia, PA; London: Saunders, 2012.
30. Mclean RA, Sanders WL, Stroup WW. A unified approach to mixed linear-models. Am Statist 1991;45:54-64.
31. Tibshirani R. Regression Shrinkage and Selection via the Lasso. J R Stat Soc B (Methodol) 1996;58:267-88.
32. Friedman JH, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. 2010 2010;33:22.
33. Forslund K, Hildebrand F, Nielsen T, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015;528:262-6.
34. Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 2012;61:582-8.
35. Costalonga M, Herzberg MC. The oral microbiome and the immunobiology of periodontal disease and caries. Immunol Lett 2014;162:22-38.
36. Swidsinski A, Schlien P, Pernthaler A, et al. Bacterial biofilm within diseased pancreatic and biliary tracts. Gut 2005;54:388-95.
37. Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2011;108(Suppl 1):4592-8.
38. Gaetti-Jardim E Jr, Marcelino SL, Feitosa AC, et al. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 2009;58:1568-75.
39. Pei Z, Bini EJ, Yang L, et al. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA 2004;101:4250-5.
40. Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 2002;17:113-18.
41. Aagaard K, Ma J, Antony KM, et al. The placenta harbors a unique microbiome. Sci Transl Med 2014;6:237-65.
42. Crasta K, Daly CG, Mitchell D, et al. Bacteraemia due to dental flossing. J Clin Periodontol 2009;36:323-32.
43. Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008;117:3118-25.
44. Stathopoulou PG, Benakanakere MR, Galicia JC, et al. The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol 2009;24:11-17.
45. Duncan L, Yoshioka M, Chandad F, et al. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 2004;36:319-25.
46. Zambirinis CP, Levie E, Nguy S, et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J Exp Med 2015;212:2077-94.
47. Otomo-Corgel J, Pucher JJ, Rethman MP, et al. State of the science: chronic periodontitis and systemic health. J Evid Based Dent Pract 2012;12:20-8.
48. Greer JB, Whitcomb DC. Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol 2009;9:411-18.
49. Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011;10:497-506.
50. Torres PJ, Fletcher EM, Gibbons SM, et al. Characterization of the salivary microbiome in patients with pancreatic cancer. PeerJ 2015;3:e1373.
51. Eribe ER, Olsen I. Leptotrichia species in human infections. Anaerobe 2008;14:131-7.
52. Couturier MR, Slechta ES, Goulston C, et al. Leptotrichia bacteremia in patients receiving high-dose chemotherapy. J Clin Microbiol 2012;50:1228-32.
53. Cooreman S, Schuermans C, Van Schaeren J, et al. Bacteraemia caused by Leptotrichia trevisanii in a neutropenic patient. Anaerobe 2011;17:1-3.
54. Inman KS, Francis AA, Murray NR. Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol 2014;20:11160-81.